An increased frequency of Tfh cells related to disease severity in the peripheral blood of SSc patients has been observed, which promoted plasmablasts (CD19+CD27+CD38hi) differentiation and antibody production through the IL-21 signaling pathway (Ricard et al., 2019). The gene discussed is IL21; the disease is systemic sclerosis.